SCHEMBL13338592

SCHEMBL13338592

Cc1cc(C)cc(N(c2ccc3c4c(cccc24)-c2ccccc2-3)C(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
PABPC1 P11940 3/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KEAP1 Q14145 2/20 0.37
NFE2L2 Q16236 2/20 0.37
CRHBP P24387 2/20 0.37
CRHR2 Q13324 2/20 0.37
ALDH1A1 P00352 4/20 0.36
CASP1 P29466 4/20 0.36
HSD17B10 Q99714 3/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HIF1A Q16665 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
POLB P06746 1/20 0.35
USP2 O75604 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13338764 0.90 MAPT (0.43) MAPTPABPC1KDM4ESMN1; SMN2KEAP1
SCHEMBL13338517 0.87 KDM4E (0.45) MAPTPABPC1KDM4ESMN1; SMN2KEAP1
SCHEMBL13338413 0.85 MAPT (0.45) MAPTPABPC1KDM4ESMN1; SMN2KEAP1
SCHEMBL13338368 0.85 MAPT (0.50) MAPTPABPC1KDM4ESMN1; SMN2KEAP1
SCHEMBL13338456 0.81 CASP1 (0.41) MAPTPABPC1KDM4ESMN1; SMN2KEAP1
SCHEMBL13338690 0.80 MAPT (0.41) MAPTPABPC1KDM4ESMN1; SMN2KEAP1
SCHEMBL13338582 0.80 CYP1A2 (0.33) ALDH1A1HSD17B10HPGDTSHRL3MBTL1
SCHEMBL14010657 0.79 MAPT (0.40) MAPTPABPC1KDM4ESMN1; SMN2KEAP1
SCHEMBL13338476 0.79 SIGMAR1 (0.41) ALDH1A1HSD17B10HPGDCYP1A2CYP3A4
SCHEMBL13338580 0.79 ALDH1A1 (0.42) MAPTKDM4ESMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 MAPT 3478/4885PABPC1 4474/4885KDM4E 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.